Characterization of multicomponent crystal formed between indomethacin and lidocaine

Drug Development and Industrial Pharmacy

Volumn 35, Issue 7, 2009, Pages 843-851

  Umeda, Yukiko ^a   Fukami, Toshiro ^b   Furuishi, Takayuki ^b   Suzuki, Toyofumi ^b   Tanjoh, Katsuhisa ^a   Tomono, Kazuo ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Crystal; Indomethacin; Lidocaine; Multicomponent; Pharmaceutical salts

Indexed keywords

ALCOHOL; INDOMETACIN; LIDOCAINE; SOLVENT;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SYNTHESIS; ENERGY; FORCE; GRINDING; HEAT TREATMENT; INFRARED SPECTROSCOPY; LIQUID; POWDER; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID STATE; X RAY DIFFRACTION;

CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; INDOMETHACIN; LIDOCAINE; POWDERS; X-RAY DIFFRACTION;

EID: 70350625183     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802660489     Document Type: Article

References (27)

1. Rodríguez-Spong B, Price CP, Jayasankar A, Matzger AJ, Rodríguez-Hornedo N. (2004). General principles of pharmaceutical solid polymorphism: A supramolecular perspective. Adv Drug Deliv Rev, 56:241-274
2. Bernstein J. (2005). Cultivating crystal forms. Chem Commun, 40:5007-5012
3. Stahly GP. (2007). Diversity in single- and multiple-component crystals. The search for and prevalence of polymorphs and cocrystals. Cryst Growth Des, 7(6):1007-1026
4. Jayasankar A, Somwangthanaroj A, Shao ZJ, Rodríguez- Hornedo N. (2006). Cocrystal formation during cogrinding and storage is mediated by amorphous phase. Pharm Res, 23(10):2381-2392
5. Childs SL, Hardcastle KI. (2007). Cocrystals of piroxicam with carboxylic acids. Cryst Growth Des, 7(7):1291-1304
6. Higgins WM, Dunker MFW. (1944). Reaction of theophylline with barbiturates. J Am Pharm Assoc 33:310-314
7. Vishweshwar P, Mcmahon JA, Bis JA, Zaworotko MJ. (2006). Pharmaceutical cocrystals. J Pharm Sci, 95(3):499-516.
8. Umeda Y, Fukami T, Furuishi T, Suzuki T, Makimura M, Tomono K. (2007). Molecular complex consisting of two typical external medicines: Intermolecular interaction between indomethacin and lidocaine. Chem Pharm Bull, 55(5):832-836
9. Umeda Y, Nagase H, Makimura M, Tomono K, Shiro M, Ueda H. (2007). Crystal structure of a 2:1 complex of indomethacin and lidocaine. Anal Sci, 23:x15-6.
10. Takahashi Y, Nakakoshi M, Sakurai S, Akiyama Y, Suematsu H, Utsumi H, et al. (2007). Development of an NMR interface microchip 'MICCS' for direct detection of reaction products and intermediates of micro-syntheses using a 'MICCS-NMR'. Anal Sci, 23:395-400.
11. Nakakoshi M, Ueda M, Sakurai S, Asakura K, Utsumi H, Miyata O, et al. (2007). Direct observation of the unstable intermediates in radical addition reaction by using an interfacing microchip combined with an NMR. Magn Reson Chem, 45:989-992
12. Otsuka M, Matsumoto T, Kaneniwa N. (1986). Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. Chem Pharm Bull, 34(4):1784-1793 (Pubitemid 16118546)
13. Legendre B, Feutelais Y. (2004). Polymorphic and thermodynamic study of indomethacin. J Therm Anal Calorim, 76:255-264
14. Cui Y, Frank SG. (2006). Characterization of supersaturated lidocaine/polyacrylate pressure sensitive adhesive systems: Thermal analysis and FT-IR. J Pharm Sci, 95(3):701-713
15. Marini A, Berbenni V, Moioli S, Bruni G, Cofrancesco P, Margheritis C, et al. (2003). Drug excipient compatibility studies by physico-chemical techniques: The case of indomethacin. J Therm Anal Calorim, 73:529-545
16. Chen X, Griesser UJ, Te RL, Pfeiffer RR, Morris KR, Stowell JG, et al. (2005). Analysis of the acid-base reaction between solid indomethacin and sodium bicarbonate using infrared spectroscopy, X-ray powder diffraction, and solid-state nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal, 38:670-677
17. Oguchi T, Kazama K, Fukami T, Yonemochi E, Yamamoto K. (2003). Specific complexation of ursodeoxycholic acid with guest compounds induced by co-grinding. II. Effect of grinding temperature on the mechanochemical complexation. Bull Chem Soc Jpn, 76(3):515-521
18. Childs SL, Stahly GP, Park A. (2007). The salt-cocrystal continuum: The influence of crystal structure on ionization state. Mol Pharm, 4(3):323-338
19. Lide DR. (2000). CRC handbook of chemistry and physics, 81st ed. Boca Raton: CRC Press, 2-55.
20. Aakeröy CB, Fasulo ME, Desper J. (2007). Cocrystal or salt: Does it really matter? Mol Pharm, 4(3):317-322
21. Ono K, Honda H. (1992). Proton NMR chemical shift induced by ionic association on a poly(ethy1ene oxide) chain. Macromolecules, 25:6368-6369
22. Consorti CS, Suarez PAZ, Souza RF, Burrow RA, Farrar DH, Lough AJ, et al. (2005). Identification of 1,3-dialkylimidazolium salt supramolecular aggregates in solution. J Phys Chem B, 109:4341-4349
23. Rodríguez-Hornedo N, Nehm S, Seefeldt KF, Pegán-Torres Y, Falkiewicz CJ. (2007). Reaction crystallization of pharmaceutical molecular complexes. Mol Pharm, 3:362-367
24. Haynes DA, Jones W, Motherwell WDS. (2005). Occurrence of pharmaceutically acceptable anions and cations in the Cambridge structural database. J Pharm Sci, 94(10):2111-2120
25. Sarajuddin ATM, Pudipeddi M. (2002). Salt selection strategies. In: Stahl PH, Wermuth CG, eds. Handbook of pharmaceutical salts: Properties, selection and use. Weinheim/Zürich: Wiley- VCH/VHCA, 135-160.
26. Morissette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, Lemmo AV, et al. (2004). High-throughput crystallization: Polymorphs, salts, cocrystals and solvates of pharmaceutical solids. Adv Drug Deliv Rev, 56:275-300.
27. Kojima T, Onoue S, Murase N, Katoh F, Mano T, Matsuda Y. (2006). Crystalline form information from multiwell plate salt screening by use of raman microscopy. Pharm Res, 23(4):806-812